메뉴 건너뛰기




Volumn 15, Issue 5, 2014, Pages 481-482

New methods to control neuroblastoma growth

Author keywords

Apoptosis; AR A014418; GSK3; Neuroblastoma

Indexed keywords

1 (4 METHOXYBENZYL) 3 (5 NITRO 2 THIAZOLYL)UREA; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GLYCOGEN SYNTHASE KINASE 3 ALPHA; GLYCOGEN SYNTHASE KINASE 3 BETA; N-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA; THIAZOLE DERIVATIVE; TUMOR MARKER; UREA;

EID: 84899798288     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.28465     Document Type: Note
Times cited : (5)

References (11)
  • 1
    • 0035413599 scopus 로고    scopus 로고
    • Phosphoinositideregulated kinases and phosphoinositide phosphatases
    • PMID:11749378
    • Leslie NR, Biondi RM, Alessi DR. Phosphoinositideregulated kinases and phosphoinositide phosphatases. Chem Rev 2001; 101:2365-80; PMID:11749378; http://dx.doi.org/10.1021/cr000091i
    • (2001) Chem Rev , vol.101 , pp. 2365-2380
    • Leslie, N.R.1    Biondi, R.M.2    Alessi, D.R.3
  • 2
    • 84884903877 scopus 로고    scopus 로고
    • Activator or inhibitor? GSK-3 as a new drug target
    • PMID:23643839
    • Takahashi-Yanaga F. Activator or inhibitor? GSK-3 as a new drug target. Biochem Pharmacol 2013; 86:191-9; PMID:23643839; http://dx.doi.org/10.1016/j. bcp.2013.04.022
    • (2013) Biochem Pharmacol , vol.86 , pp. 191-199
    • Takahashi-Yanaga, F.1
  • 3
    • 84884688237 scopus 로고    scopus 로고
    • Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells
    • PMID:23877009
    • Sajithlal GB, Hamed HA, Cruickshanks N, Booth L, Tavallai S, Syed J, Grant S, Poklepovic A, Dent P. Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells. Mol Pharmacol 2013; 84:562-71; PMID:23877009; http://dx.doi.org/10.1124/mol.113. 088005
    • (2013) Mol Pharmacol , vol.84 , pp. 562-571
    • Sajithlal, G.B.1    Hamed, H.A.2    Cruickshanks, N.3    Booth, L.4    Tavallai, S.5    Syed, J.6    Grant, S.7    Poklepovic, A.8    Dent, P.9
  • 4
    • 84874334011 scopus 로고    scopus 로고
    • Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibitioninduced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism
    • PMID:23243017
    • Rahmani M, Aust MM, Attkisson E, Williams DC Jr., Ferreira-Gonzalez A, Grant S. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibitioninduced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism. Cancer Res 2013; 73:1340-51; PMID:23243017; http://dx.doi.org/10.1158/0008-5472.CAN-12-1365
    • (2013) Cancer Res , vol.73 , pp. 1340-1351
    • Rahmani, M.1    Aust, M.M.2    Attkisson, E.3    Williams Jr., D.C.4    Ferreira-Gonzalez, A.5    Grant, S.6
  • 5
    • 77953523121 scopus 로고    scopus 로고
    • Recent advances in neuroblastoma
    • PMID:20558371
    • Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010; 362:2202-11; PMID:20558371; http://dx.doi.org/10.1056/NEJMra0804577
    • (2010) N Engl J Med , vol.362 , pp. 2202-2211
    • Maris, J.M.1
  • 6
    • 0030919377 scopus 로고    scopus 로고
    • Neuroblastoma in adults and adolescents: An indolent course with poor survival
    • DOI 10.1002/(SICI)1097-0142(19970515)79:10<2028::AID-CNCR26>3.0. CO;2-V
    • Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 1997; 79:2028-35; PMID:9149032; http://dx.doi.org/10.1002/(SICI)1097-0142(19970515)79: 10<2028::AIDCNCR26>3.0.CO;2-V (Pubitemid 27200389)
    • (1997) Cancer , vol.79 , Issue.10 , pp. 2028-2035
    • Franks, L.M.1    Bollen, A.2    Seeger, R.C.3    Stram, D.O.4    Matthay, K.K.5
  • 7
    • 84899842513 scopus 로고    scopus 로고
    • Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth
    • PMID:24521712
    • Carter YM, Kunnimalaiyaan S, Chen H, Gamblin TC, Kunnimalaiyaan M. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth. Cancer Biol Ther 2014; 15:510-5; PMID:24521712; http://dx.doi.org/10.4161/cbt.28015
    • (2014) Cancer Biol Ther , vol.15 , pp. 510-515
    • Carter, Y.M.1    Kunnimalaiyaan, S.2    Chen, H.3    Gamblin, T.C.4    Kunnimalaiyaan, M.5
  • 8
    • 84886259126 scopus 로고    scopus 로고
    • Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma
    • PMID:24034838
    • Madhunapantula SV, Sharma A, Gowda R, Robertson GP. Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma. Pigment Cell Melanoma Res 2013; 26:886-99; PMID:24034838; http://dx.doi.org/10.1111/ pcmr.12156
    • (2013) Pigment Cell Melanoma Res , vol.26 , pp. 886-899
    • Madhunapantula, S.V.1    Sharma, A.2    Gowda, R.3    Robertson, G.P.4
  • 10
    • 84864610364 scopus 로고    scopus 로고
    • The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice
    • PMID:22698482
    • Ahn SW, Kim JE, Park KS, Choi WJ, Hong YH, Kim SM, Kim SH, Lee KW, Sung JJ. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice. J Neurol Sci 2012; 320:1-5; PMID:22698482; http://dx.doi.org/10.1016/j.jns.2012.05.038
    • (2012) J Neurol Sci , vol.320 , pp. 1-5
    • Ahn, S.W.1    Kim, J.E.2    Park, K.S.3    Choi, W.J.4    Hong, Y.H.5    Kim, S.M.6    Kim, S.H.7    Lee, K.W.8    Sung, J.J.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.